Niki BioSolutions Flags Substantial Doubt About Going Concern in First Post-Merger Financials
NIKI sits 43% above its 52-week low of $6 on light trading volume (0.4× avg).
Summary
Niki BioSolutions disclosed a going concern warning in its first post-merger financials, citing substantial doubt about its ability to continue as a going concern within one year.
Updates
· Reuters — H1 net loss widened to $1.60 per share, and the company is weighing financing options to shore up liquidity.
Key Events · Earnings and Guidance · NIKI
-
Going Concern Warning
Management determined that conditions raise substantial doubt about the Group's ability to continue as a going concern within one year after the date these financial statements are issued.
-
Six-Month Financial Results
Net loss of $1,307,300, negative working capital of $2,475,418, net operating cash outflow of $1,553,720, and accumulated deficit of $75,118,802 as of June 30, 2026.
-
DiamiR Capital Shortfall
DiamiR's standalone financial statements indicate its existing capital is not expected to be sufficient to fund operations for the next twelve months without additional financing.
-
Warrant Liability Gain
Recognized a non-cash gain of $164,000 from the change in fair value of warrant liability for the six months ended June 30, 2026.
Analysis · NIKI · Industrial Applications And Services
The company's first financial report after the DiamiR merger reveals a going concern warning. Management states substantial doubt about the company's ability to continue as a going concern within one year. The six-month results show a net loss of $1.3 million, negative working capital of $2.5 million, and cash burn of $1.6 million. DiamiR, the acquired entity, also lacks sufficient capital to fund operations for the next twelve months without additional financing. This is a critical disclosure for a micro-cap company with a market cap of only $7 million.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NIKI was trading at $8.58 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7M. The 52-week trading range was $6.00 to $44.70. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.